DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Hadji P, Bock O, Resch H. et al.
Reduction of fracture risk with denosumab among women with osteoporosis with or without need for treatment according to DVO guideline. A subgroup analysis of the FREEDOM trial.
Osteologie 2013; 39-45
Access:
We do not assume any responsibility for the contents of the web pages of other providers.